Published in Gene Therapy Weekly, November 8th, 1999
"The toxic effects of tumor necrosis factor alpha (TNF alpha) have greatly limited its use in tumor therapy," wrote R.A. Marr and colleagues, McMaster University. "Recently, clear evidence has been obtained linking the p55 TNF receptor (TNFR) to the induction of systemic toxicity. We have generated a p75 murine TNFR (mTNFR)-specific mutant of mTNF alpha (D142 N-A144R), cloned this gene into a recombinant adenovirus vector (Ad-75), and studied its...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.